Article
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
JAMA oncology - 1 Aug 2016
Sacher Adrian G, Paweletz Cloud, Dahlberg Suzanne E, Alden Ryan S, O'Connell Allison, Feeney Nora, Mach Stacy L, Jänne Pasi A, Oxnard Geoffrey R
Abstract excerpt
IMPORTANCE: Plasma genotyping of cell-free DNA has the potential to allow for rapid noninvasive genotyping while avoiding the inherent shortcomings of tissue genotyping and repeat biopsies. OBJECTIVE: To prospectively validate plasma droplet digital PCR (ddPCR) for the rapid detection of common epidermal growth factor receptor (EGFR) and KRAS mutations, as well as the EGFR T790M acquired resistance mutation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
